|Allison Wey||Senior Vice President of Investor Relations|
|Paul Edick||Chairman & Chief Executive Officer|
|Barry Deutsch||Chief Financial Officer|
|David Amsellem||Piper Sandler|
|Ami Fadia||SVB Leerink|
|Difei Yang||Mizuho Group|
Ladies and gentlemen, thank you for standing by. And welcome to today's Xeris Pharmaceuticals Fourth Quarter Final Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker, Allison Wey, Senior Vice President of Investor Relations.